BPG is committed to discovery and dissemination of knowledge
Articles in Press
6/7/2021 1:23:23 PM | Browse: 54 | Download: 15
Publication Name World Journal of Immunology
Manuscript ID 62657
Country/Territory Spain
Category Medicine, Research and Experimental
Manuscript Type Minireviews
Article Title New era of personalized medicine: Advanced therapy medicinal products in Europe
Manuscript Source Unsolicited Manuscript
All Author List Javier García-González, Sonia Marhuenda-Castillo, Sheila Romero-Carretero and Jesús Beltrán-García
Funding Agency and Grant Number
Corresponding Author Jesús Beltrán-García, PhD, Academic Research, Department of Physiology, Faculty of Medicine and Dentistry, University of Valencia, Av. de Blasco Ibáñez, 15, Valencia 46010, Spain. jesus.beltran@ext.uv.es
Key Words Advanced therapy; Advanced therapy medicinal products; Cell therapy; Gene therapy; Tissue therapy; Chimeric antigen receptor T cell
Core Tip The advanced therapy medicinal products (ATMPs) have opened a new world of possibilities in the prevention and treatment of a large number of diseases that have not been effectively treated to date. ATMPs are based on the use of novel and sophisticated technologies adapted to each patient (personalized medicine), as well as on the discovery of novel and reliable biomarkers for the prediction and monitoring of clinical response. In this work we describe the latest advances in ATMPs approved by the European Medicines Agency, the molecular mechanisms that guided their medical benefits, how they work, the current status, and how they can change the medicine field forever, approaching precision personalized medicine.
Citation García-González J, Marhuenda-Castillo S, Romero-Carretero S, Beltrán-García J. New era of personalized medicine: Advanced therapy medicinal products in Europe. World J Immunol 2021; In press
2021-01-14 09:10
Peer-Review Started
2021-01-14 09:12
To Make the First Decision
Return for Revision
2021-02-15 03:49
2021-02-24 11:41
Second Decision
2021-06-07 12:29
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2021-06-07 13:23
Articles in Press
2021-06-07 13:23
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 2219-2824 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Assistant Editor Assistant Editor
Science Editor Chen-Chen Gao
Reviewer Code 05622174, and 02558570
Editorial Director
Journal Chief Editor
Company Chief Editor Ze-Mao Gong
Language Editor
Production Editor
Responsible Production Editor
Responsible Science Editor
Proofing Editorial Director Jin-Lei Wang
Proofing Editor-in-Chief Lian-Sheng Ma
Manuscript File 62657_Auto_Edited-ZMG.docx
Answering Reviewers 62657-Answering reviewers.pdf
Audio Core Tip 62657-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 62657-Conflict-of-interest statement.pdf
Copyright License Agreement 62657-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate 62657-Language certificate.pdf
Peer-review Report 62657-Peer-review(s).pdf
Scientific Misconduct Check 62657-Bing-Wang JL-1.jpg
Scientific Misconduct Check 62657-Scientific misconduct check.pdf
Scientific Editor Work List 62657-Scientific editor work list.pdf